Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Does micropapillary subtype for a G1-2 DCIS affect your radiation treatment recommendations?
Are you more likely to recommend radiation over omission? Whole breast over APBI?
Answer from: Radiation Oncologist at Community Practice
It doesn’t change the recommendation. If adequate, imaging and surgery are done, like any other DCIS.
Sign In
or
Register
to read more
28151
Related Questions
What are your top takeaways in Breast Cancer from ESMO 2024?
How would you approach reirradiation in a patient with a history of whole-breast RT many years ago, now with a small intermediate-grade DCIS s/p lumpectomy with an elevated DCISionRT?
When using hypofractionated whole breast radiotherapy with a simultaneous integrated boost to the lumpectomy cavity, what IGRT strategy do you use?
How do you advise women to manage wound care for breast brachytherapy needle sites for long term cosmetic outcomes?
How would you approach the treatment of low grade, stage IA, triple negative apocrine adenocarcinoma of the breast in a female patient in her 70s?
For patients between 40-49 years old who undergo lumpectomy, how do you choose between offering PBI per the updated PBI guidelines or boosting based on boost guidelines?
How do you approach reirradiation in a patient who underwent breast-conserving surgery for recurrent breast cancer after initial lumpectomy and APBI?
Would you consider 5-fraction whole breast RT for a patient with multiple positive margins following lumpectomy for whom reexcision is not possible?
What are your top takeaways in Breast Cancer from ASCO 2025?
Does a post-surgical hematoma in the breast affect your recommendations for partial breast RT?